Tenders/DoW Peer Reviewed Cancer, Clinical Trial Award

DoW Peer Reviewed Cancer, Clinical Trial Award

Dept. of the Army -- USAMRAA
Published: May 6, 2026
Updated: Jun 18, 2026
Source: grants_gov

About This Opportunity

Grant contract by Dept (United States): DoW Peer Reviewed Cancer, Clinical Trial Award. healthcare. Submission deadline Oct 2026.

This is a grants contract in the health and medical services and Research sectors, with a focus on Pharmaceuticals. Located in United States, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before October 5, 2026.

Published through Grants.gov, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for grants in the health and medical services sector. Grant applications generally require a detailed project proposal, a clear results framework, and evidence of the applicant's capacity to deliver the proposed activities. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations.

Distinctive Features: • Applications to this award mechanism must include a clinical trial. • Projects can range from phase 0 to phase III. • If an Investigational New Drug (IND) application, Investigational Device Exemption (IDE), or equivalent, is required, a regulatory application must be submitted to the relevant regulatory agency by the Clinical Trial Award application submission deadline. The regulatory application should be specific to the product and indication to be tested in the proposed clinical trial. • Applications are required to include patient advocates. • Animal studies are NOT allowed under this award mechanism. All preclinical work must be completed prior to the award start date.

Agency: Abigail Strock
Contract Specialist

CFDA: 12.420

Applicant Types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Cost Sharing: No

Contact: Abigail Strock
Contract Specialist

Email: help@eBRAP.org

Data provenance

This notice is sourced from Grants.gov and was originally published on May 6, 2026. Last refreshed 6 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dept. of the Army -- USAMRAA

Dept. of the Army -- USAMRAA has issued 77 procurement notices on BidsFactory, including 77 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for United States. Notices are distributed via Grants.gov. Most recent publication: June 17, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Grants contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Grants.gov to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is October 5, 2026. You have 103 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Dept. of the Army -- USAMRAA in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Key Details

Submission Deadline
Oct 5, 2026
103 days remaining
Contract Type
Grants
Eligibility
Firms / Consortiums
Language
English

Source

grants_gov
grants_gov
Official Source

Contracting Authority

Dept. of the Army -- USAMRAA
🇺🇸United States

Contact

Contact Person
Abigail Strock Contract Specialist

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.